|
KPNB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.53480000000461E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.114430E-01 |
| Normal-vs-Stage2 |
1.168780E-01 |
| Normal-vs-Stage3 |
7.557900E-04 |
| Normal-vs-Stage4 |
2.867900E-02 |
| Stage1-vs-Stage2 |
2.242600E-01 |
| Stage1-vs-Stage3 |
6.378300E-04 |
| Stage1-vs-Stage4 |
7.755800E-03 |
| Stage2-vs-Stage3 |
2.237800E-01 |
| Stage2-vs-Stage4 |
2.454200E-01 |
| Stage3-vs-Stage4 |
7.939200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.94629999999663E-05 |
| Normal-vs-AfricanAmerican |
8.684500E-02 |
| Normal-vs-Asian |
2.788800E-01 |
| Caucasian-vs-AfricanAmerican |
3.526600E-01 |
| Caucasian-vs-Asian |
3.913600E-01 |
| AfricanAmerican-vs-Asian |
2.313600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.811820E-02 |
| Normal-vs-Female |
1.74780000028463E-07 |
| Male-vs-Female |
1.151110E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.790400E-02 |
| Normal-vs-Extreme_Weight |
3.090800E-01 |
| Normal-vs-Obese |
1.456750E-03 |
| Normal-vs-Extreme_Obese |
7.893800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.504000E-01 |
| Normal_Weight-vs-Obese |
5.337400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.004600E-01 |
| Extreme_Weight-vs-Obese |
2.367900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.696400E-01 |
| Obese-vs-Extreme_Obese |
2.277000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.637200E-03 |
| Normal-vs-Age(41-60Yrs) |
9.71269999983093E-07 |
| Normal-vs-Age(61-80Yrs) |
1.811780E-01 |
| Normal-vs-Age(81-100Yrs) |
9.773200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.260400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.113820E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.140100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.415130E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.159600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.400200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.904500E-02 |
| Normal-VS-Type2 PRCC |
1.100720E-03 |
| Normal-VS-KIRP CIMP |
1.323070E-03 |
| Normal-VS-Unclassified PRCC |
3.222600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.619800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.418800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.268400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.237420E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.600400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.420900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.582000E-01 |
| Normal-vs-N1 |
1.401730E-04 |
| Normal-vs-N2 |
1.335190E-01 |
| N0-vs-N1 |
1.284240E-03 |
| N0-vs-N2 |
2.028200E-02 |
| N1-vs-N2 |
8.943600E-01 |
|
|
